Global Oncology Information Systems Market - 2025-2033
Description
Global Oncology Information Systems Market: Industry Outlook
The global oncology information systems market reached US$ 2.70 Billion in 2024 and is expected to reach US$ 5.74 Billion by 2033, growing at a CAGR of 8.8% during the forecast period 2025-2033.
Oncology information systems (OIS) manage data on cancer patient hospitalization programs, treatment deliveries, plans, and diagnostic results.
The global Oncology Information Systems (OIS) market is experiencing significant growth due to the increasing cancer incidence, adoption of advanced healthcare IT solutions, and demand for integrated cancer care. OIS helps healthcare providers manage cancer treatment workflows, patient scheduling, and electronic medical records. However, challenges like high implementation costs, data security concerns, and skilled professionals in developing regions may hinder market expansion.
North America currently dominates the market due to its advanced healthcare infrastructure, while the Asia-Pacific region is expected to experience the fastest growth due to increasing healthcare investments and cancer prevalence.
Global Oncology Information Systems Market Dynamics: Drivers & Restraints
Driver: Increasing Prevalence of Cancer Worldwide
The global cancer incidence is driving the growth of the oncology information systems (OIS) market. With millions of new cancer cases diagnosed annually, healthcare systems need efficient, technology-driven solutions. OIS platforms streamline patient data management, facilitate accurate treatment planning, and enable real-time monitoring, contributing to the expansion of the global OIS market.
For instance, as per the International Agency for Research on Cancer, globally, nearly 20 Billion incident cases were reported in 2022. In 2030, nearly 24.10 Billion cases and in 2040, nearly 29.90 Billion cases were expected.
Hence, the rise in cancer incidence helps the healthcare providers face pressure to deliver timely, accurate, and personalized treatment. OIS platforms manage large patient data, support complex treatment planning, and improve workflow efficiency. The growing patient load requires scalable digital solutions to coordinate care across departments and specialists. This trend is accelerating OIS adoption in hospitals, oncology centers, and research institutions, contributing to global market expansion.
Restraint: Data Security and Privacy Concerns
The global oncology information systems market faces challenges in data security and patient privacy due to the growing adoption of cloud-based solutions and stringent data protection regulations. Ensuring end-to-end encryption, secure user authentication, and system interoperability presents technical and operational challenges, potentially slowing market growth in regions with limited cybersecurity infrastructure or regulatory clarity.
Global Oncology Information Systems Market Segment Analysis
The global oncology information systems market is segmented based on product & services, application, end user, and region.
Product & Services:
The software segment of the product & services is expected to hold 54.5% in the oncology information Systems market
The software segment in the oncology information systems market is experiencing significant growth due to the need for centralized data management, improved treatment planning, and real-time patient monitoring. The rise in cancer incidence is driving healthcare providers to adopt advanced digital tools for efficient clinical workflows and improved patient outcomes.
The shift towards value-based care and personalized medicine has increased demand for integrated software systems for data-driven decision-making and tailored treatment protocols. Technological advancements in AI, cloud computing, and big data analytics are enhancing oncology software's capabilities.
For instance, in May 2204, GE HealthCare unveiled Revolution RT, a new radiation therapy CT solution with innovative hardware and software, aiming to increase imaging accuracy and simplify simulation workflow. The AI-enhanced Intelligent Radiation Therapy platform interfaces with the Spectronic MRI Planner.
Global Oncology Information Systems Market- Geographical Analysis
North America dominated the global oncology information systems market with the highest share of 42.3% in 2024
North America dominates the global oncology information systems market due to advanced healthcare infrastructure, high IT adoption, and significant cancer research investments. The region benefits from EHR integration and interoperability policies. The growing number of cancer cases and focus on precision medicine in the U.S. and Canada encourage healthcare providers to adopt robust OIS platforms. Key market players, technological advancements, and favorable reimbursement scenarios further accelerate the market's growth.
For instance, the American Cancer Society predicts that by 2025, the US will experience 2,041,910 new cancer cases and 618,120 deaths, based on data from central cancer registries and the National Center for Health Statistics. This data is based on population-based cancer occurrence and outcomes.
Asia-Pacific region in the global oncology information systems market is expected to grow with the highest CAGR of 18.5% in the forecast period of 2025 to 2033
The Asia Pacific region is experiencing rapid growth in the oncology information systems market due to rising cancer prevalence, healthcare expenditure, and awareness of advanced technologies. Countries like China, India, and Japan are investing in digital healthcare infrastructure to improve care delivery and patient outcomes. Government initiatives, electronic health records, and telemedicine are driving demand for integrated systems. The rising burden of cancer cases in densely populated areas prompts hospitals to streamline workflows using comprehensive information systems for efficient patient data management and outcome monitoring.
For instance, in September 2024, the Indian Cancer Genome Atlas (ICGA) launched India's first comprehensive cancer multi-omics data portal, offering open access to clinically correlated data from Indian cancer patients, aiming to transform cancer research and treatment.
Global Oncology Information Systems Market- Key Players
The major global players in the oncology information systems market include Koninklijke Philips N.V., Varian Medical Systems, McKesson Corporation, Elekta AB, Epic Systems Corporation, IBM, Cerner Corporation, Advanced Data Systems, and Bogardus Medical Systems, Inc., among others.
Industry Trends
• In January 2024, Apollo Cancer Centre in Bengaluru launched India's first AI-Precision Oncology Centre (POC), enhancing oncology care quality. The centre provides comprehensive medical services, including accurate diagnosis, real-time insights, cancer risk assessment, treatment protocol, and care continuum. It is patient-centric, identifying eligible patients for targeted therapy and immunotherapy, and educating patients and families.
The global oncology information systems market reached US$ 2.70 Billion in 2024 and is expected to reach US$ 5.74 Billion by 2033, growing at a CAGR of 8.8% during the forecast period 2025-2033.
Oncology information systems (OIS) manage data on cancer patient hospitalization programs, treatment deliveries, plans, and diagnostic results.
The global Oncology Information Systems (OIS) market is experiencing significant growth due to the increasing cancer incidence, adoption of advanced healthcare IT solutions, and demand for integrated cancer care. OIS helps healthcare providers manage cancer treatment workflows, patient scheduling, and electronic medical records. However, challenges like high implementation costs, data security concerns, and skilled professionals in developing regions may hinder market expansion.
North America currently dominates the market due to its advanced healthcare infrastructure, while the Asia-Pacific region is expected to experience the fastest growth due to increasing healthcare investments and cancer prevalence.
Global Oncology Information Systems Market Dynamics: Drivers & Restraints
Driver: Increasing Prevalence of Cancer Worldwide
The global cancer incidence is driving the growth of the oncology information systems (OIS) market. With millions of new cancer cases diagnosed annually, healthcare systems need efficient, technology-driven solutions. OIS platforms streamline patient data management, facilitate accurate treatment planning, and enable real-time monitoring, contributing to the expansion of the global OIS market.
For instance, as per the International Agency for Research on Cancer, globally, nearly 20 Billion incident cases were reported in 2022. In 2030, nearly 24.10 Billion cases and in 2040, nearly 29.90 Billion cases were expected.
Hence, the rise in cancer incidence helps the healthcare providers face pressure to deliver timely, accurate, and personalized treatment. OIS platforms manage large patient data, support complex treatment planning, and improve workflow efficiency. The growing patient load requires scalable digital solutions to coordinate care across departments and specialists. This trend is accelerating OIS adoption in hospitals, oncology centers, and research institutions, contributing to global market expansion.
Restraint: Data Security and Privacy Concerns
The global oncology information systems market faces challenges in data security and patient privacy due to the growing adoption of cloud-based solutions and stringent data protection regulations. Ensuring end-to-end encryption, secure user authentication, and system interoperability presents technical and operational challenges, potentially slowing market growth in regions with limited cybersecurity infrastructure or regulatory clarity.
Global Oncology Information Systems Market Segment Analysis
The global oncology information systems market is segmented based on product & services, application, end user, and region.
Product & Services:
The software segment of the product & services is expected to hold 54.5% in the oncology information Systems market
The software segment in the oncology information systems market is experiencing significant growth due to the need for centralized data management, improved treatment planning, and real-time patient monitoring. The rise in cancer incidence is driving healthcare providers to adopt advanced digital tools for efficient clinical workflows and improved patient outcomes.
The shift towards value-based care and personalized medicine has increased demand for integrated software systems for data-driven decision-making and tailored treatment protocols. Technological advancements in AI, cloud computing, and big data analytics are enhancing oncology software's capabilities.
For instance, in May 2204, GE HealthCare unveiled Revolution RT, a new radiation therapy CT solution with innovative hardware and software, aiming to increase imaging accuracy and simplify simulation workflow. The AI-enhanced Intelligent Radiation Therapy platform interfaces with the Spectronic MRI Planner.
Global Oncology Information Systems Market- Geographical Analysis
North America dominated the global oncology information systems market with the highest share of 42.3% in 2024
North America dominates the global oncology information systems market due to advanced healthcare infrastructure, high IT adoption, and significant cancer research investments. The region benefits from EHR integration and interoperability policies. The growing number of cancer cases and focus on precision medicine in the U.S. and Canada encourage healthcare providers to adopt robust OIS platforms. Key market players, technological advancements, and favorable reimbursement scenarios further accelerate the market's growth.
For instance, the American Cancer Society predicts that by 2025, the US will experience 2,041,910 new cancer cases and 618,120 deaths, based on data from central cancer registries and the National Center for Health Statistics. This data is based on population-based cancer occurrence and outcomes.
Asia-Pacific region in the global oncology information systems market is expected to grow with the highest CAGR of 18.5% in the forecast period of 2025 to 2033
The Asia Pacific region is experiencing rapid growth in the oncology information systems market due to rising cancer prevalence, healthcare expenditure, and awareness of advanced technologies. Countries like China, India, and Japan are investing in digital healthcare infrastructure to improve care delivery and patient outcomes. Government initiatives, electronic health records, and telemedicine are driving demand for integrated systems. The rising burden of cancer cases in densely populated areas prompts hospitals to streamline workflows using comprehensive information systems for efficient patient data management and outcome monitoring.
For instance, in September 2024, the Indian Cancer Genome Atlas (ICGA) launched India's first comprehensive cancer multi-omics data portal, offering open access to clinically correlated data from Indian cancer patients, aiming to transform cancer research and treatment.
Global Oncology Information Systems Market- Key Players
The major global players in the oncology information systems market include Koninklijke Philips N.V., Varian Medical Systems, McKesson Corporation, Elekta AB, Epic Systems Corporation, IBM, Cerner Corporation, Advanced Data Systems, and Bogardus Medical Systems, Inc., among others.
Industry Trends
• In January 2024, Apollo Cancer Centre in Bengaluru launched India's first AI-Precision Oncology Centre (POC), enhancing oncology care quality. The centre provides comprehensive medical services, including accurate diagnosis, real-time insights, cancer risk assessment, treatment protocol, and care continuum. It is patient-centric, identifying eligible patients for targeted therapy and immunotherapy, and educating patients and families.
Table of Contents
180 Pages
- 1. Market Introduction and Scope
- 1.1. Objectives of the Report
- 1.2. Report Coverage & Definitions
- 1.3. Report Scope
- 2. Executive Insights and Key Takeaways
- 2.1. Market Highlights and Strategic Takeaways
- 2.2. Key Trends and Future Projections
- 2.3. Snippet by Product & Services
- 2.4. Snippet by Application
- 2.5. Snippet by End User
- 2.6. Snippet by Region
- 3. Dynamics
- 3.1. Impacting Factors
- 3.1.1. Drivers
- 3.1.1.1. Increasing Prevalence of Cancer Worldwide
- 3.1.1.2. Rising Adoption of Electronic Health Records (EHRs)
- 3.1.1.3. XX
- 3.1.2. Restraints
- 3.1.2.1. High cost of OIS Implementation and Maintenance
- 3.1.2.2. Data Security and Privacy Concerns
- 3.1.2.3. XX
- 3.1.3. Opportunity
- 3.1.3.1. Growing Adoption of Cloud-based OIS Solutions
- 3.1.3.2. XX
- 3.1.4. Impact Analysis
- 4. Strategic Insights and Industry Outlook
- 4.1. Market Leaders and Pioneers
- 4.1.1. Emerging Pioneers and Prominent Players
- 4.1.2. Established leaders with largest largest-selling Brand
- 4.1.3. Market leaders with established products & Services
- 4.2. CXO Perspectives
- 4.3. Latest Developments and Breakthroughs
- 4.4. Case Studies/Ongoing Research
- 4.5. Regulatory and Reimbursement Landscape
- 4.5.1. North America
- 4.5.2. Europe
- 4.5.3. Asia Pacific
- 4.5.4. South America
- 4.5.5. Middle East & Africa
- 4.6. Porter’s Five Force Analysis
- 4.7. Supply Chain Analysis
- 4.8. Patent Analysis
- 4.9. SWOT Analysis
- 4.10. Unmet Needs and Gaps
- 4.11. Recommended Strategies for Market Entry and Expansion
- 4.12. Scenario Analysis: Best-Case, Base-Case, and Worst-Case Forecasts
- 4.13. Pricing Analysis and Price Dynamics
- 4.14. Key Opinion Leaders
- 5. Global Oncology Information Systems Market, By Product & Services
- 5.1. Introduction
- 5.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product & Services
- 5.1.2. Market Attractiveness Index, By Product & Services
- 5.2. Software*
- 5.2.1. Introduction
- 5.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
- 5.2.3. Patient Information Systems
- 5.2.4. Treatment Planning Systems
- 5.2.5. Treatment Management Systems & Medical Image Analysis Systems
- 5.3. Services
- 5.3.1. Consulting/Optimization Services
- 5.3.2. Implementation Services
- 5.3.3. Post-Sale and Maintenance Services
- 6. Global Oncology Information Systems Market, By Application
- 6.1. Introduction
- 6.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 6.1.2. Market Attractiveness Index, By Application
- 6.2. Radiation Oncology*
- 6.2.1. Introduction
- 6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
- 6.3. Medical Oncology
- 6.4. Surgical Oncology
- 7. Global Oncology Information Systems Market, By End User
- 7.1. Introduction
- 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
- 7.1.2. Market Attractiveness Index, By End User
- 7.2. Hospitals & Diagnostic Imaging Centers*
- 7.2.1. Introduction
- 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
- 7.3. Government Institutions
- 7.4. Ambulatory Surgical Centers
- 7.5. Research Facilities
- 8. Oncology Information Systems Market Regional Market Analysis and Growth Opportunities
- 8.1. Introduction
- 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
- 8.1.2. Market Attractiveness Index, By Region
- 8.2. North America
- 8.2.1. Introduction
- 8.2.2. Key Region-Specific Dynamics
- 8.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product & Services
- 8.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 8.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
- 8.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
- 8.2.6.1. U.S.
- 8.2.6.2. Canada
- 8.2.6.3. Mexico
- 8.3. Europe
- 8.3.1. Introduction
- 8.3.2. Key Region-Specific Dynamics
- 8.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product & Services
- 8.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 8.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
- 8.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
- 8.3.6.1. Germany
- 8.3.6.2. U.K.
- 8.3.6.3. France
- 8.3.6.4. Spain
- 8.3.6.5. Italy
- 8.3.6.6. Rest of Europe
- 8.4. South America
- 8.4.1. Introduction
- 8.4.2. Key Region-Specific Dynamics
- 8.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product & Services
- 8.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 8.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
- 8.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
- 8.4.6.1. Brazil
- 8.4.6.2. Argentina
- 8.4.6.3. Rest of South America
- 8.5. Asia-Pacific
- 8.5.1. Introduction
- 8.5.2. Key Region-Specific Dynamics
- 8.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product & Services
- 8.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 8.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
- 8.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
- 8.5.6.1. China
- 8.5.6.2. India
- 8.5.6.3. Japan
- 8.5.6.4. South Korea
- 8.5.6.5. Rest of Asia-Pacific
- 8.6. Middle East and Africa
- 8.6.1. Introduction
- 8.6.2. Key Region-Specific Dynamics
- 8.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product & Services
- 8.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 8.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
- 9. Competitive Landscape and Market Positioning
- 9.1. Competitive Overview and Key Market Players
- 9.2. Market Share Analysis and Positioning Matrix
- 9.3. Strategic Partnerships, Mergers & Acquisitions
- 9.4. Key Developments in Product & Services Portfolios and Innovations
- 9.5. Company Benchmarking
- 10. Company Profiles
- 10.1. Koninklijke Philips N.V.*
- 10.1.1. Company Overview
- 10.1.2. Product & Services Portfolio
- 10.1.2.1. Product & Services Description
- 10.1.2.2. Product & Services Key Performance Indicators (KPIs)
- 10.1.2.3. Historic and Forecasted Product & Services Sales
- 10.1.2.4. Product & Services Sales Volume
- 10.1.3. Financial Overview
- 10.1.3.1. Company Revenue
- 10.1.3.2. Geographical Revenue Shares
- 10.1.3.3. Revenue Forecasts
- 10.1.4. Key Developments
- 10.1.4.1. Mergers & Acquisitions
- 10.1.4.2. Key Product & Services Development Activities
- 10.1.4.3. Regulatory Approvals, etc.
- 10.1.5. SWOT Analysis
- 10.2. Varian Medical Systems
- 10.3. McKesson Corporation
- 10.4. Elekta AB
- 10.5. Epic Systems Corporation
- 10.6. IBM
- 10.7. Cerner Corporation
- 10.8. Advanced Data Systems
- 10.9. Bogardus Medical Systems, Inc
- LIST NOT EXHAUSTIVE
- 11. Assumptions and Research Methodology
- 11.1. Data Collection Methods
- 11.2. Data Triangulation
- 11.3. Forecasting Techniques
- 11.4. Data Verification and Validation
- 12. Appendix
- 12.1. About Us and Services
- 12.2. Contact Us
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
